Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
0(0%)
Results Posted
50%(1 trials)
Terminated
1(14%)

Phase Distribution

Ph phase_4
1
14%
Ph early_phase_1
1
14%
Ph not_applicable
1
14%
Ph phase_1
1
14%
Ph phase_3
2
29%

Phase Distribution

2

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution6 total trials
Early Phase 1First-in-human
1(16.7%)
Phase 1Safety & dosage
1(16.7%)
Phase 3Large-scale testing
2(33.3%)
Phase 4Post-market surveillance
1(16.7%)
N/ANon-phased studies
1(16.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Active(1)
Completed(2)
Terminated(1)
Other(3)

Detailed Status

unknown3
Completed2
Terminated1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
66.7%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (16.7%)
Phase 11 (16.7%)
Phase 32 (33.3%)
Phase 41 (16.7%)
N/A1 (16.7%)

Trials by Status

unknown343%
terminated114%
not_yet_recruiting114%
completed229%

Recent Activity

0 active trials
Showing 5 of 7
not_yet_recruitingphase_3

The PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity

NCT06494878
unknownphase_4

D-dimer Adjusted Versus Therapeutic Dose Low-molecular-weight Heparin in Patients With COVID-19 Pneumonia

NCT04584580
terminatedearly_phase_1

AntiPhospholipid Syndrome Low-molecular-weight Heparin Pregnancy Loss Evaluation: The Pilot Study

NCT03100123
completedphase_1

Rivaroxaban Versus Low-molecular-weight Heparin for Preventing Thrombosis in Cancer Patients

NCT03282643
completedphase_3

Cancer Associated Thrombosis, a Pilot Treatment Study Using Rivaroxaban

NCT02746185
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT06494878Phase 3

The PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity

Not Yet Recruiting
NCT04584580Phase 4

D-dimer Adjusted Versus Therapeutic Dose Low-molecular-weight Heparin in Patients With COVID-19 Pneumonia

Unknown
NCT03100123Early Phase 1

AntiPhospholipid Syndrome Low-molecular-weight Heparin Pregnancy Loss Evaluation: The Pilot Study

Terminated
NCT03282643Phase 1

Rivaroxaban Versus Low-molecular-weight Heparin for Preventing Thrombosis in Cancer Patients

Completed
NCT02746185Phase 3

Cancer Associated Thrombosis, a Pilot Treatment Study Using Rivaroxaban

Completed
NCT03157843

Rate of Venous Thrombosis in Acutely Ill Patients Hospitalized in Internal Medicine Wards

Unknown
NCT01029821Not Applicable

Low-Molecular-Weight Heparin (LMWH) for Deep Venous Thrombosis (DVT) Prophylaxis

Unknown

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7